Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects.

J Immunother Cancer · 2021 · PMC8491418 · PMID 34607895

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Indeed, our analyses showed a trend of T cells to move towards tumor cells following CXCL12 inhibition in all patients that were classified as tissue responders ( figure 6E ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.